{"transactions":[{"id":767710,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-21T20:30:07.000Z","date":"2026-05-19","kind":"exercise","planned":false,"acquired":false,"shares":12417,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12417},"source":{"system":"sec-edgar","filing":"0001193125-26-234565","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526234565/ownership.xml","form_type":"4"}},{"id":767709,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T20:30:07.000Z","date":"2026-05-19","kind":"exercise","planned":false,"acquired":true,"shares":12417,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."}],"balance_after":110623,"source":{"system":"sec-edgar","filing":"0001193125-26-234565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526234565/ownership.xml","form_type":"4"}},{"id":819275,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T18:52:06.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":755,"price":9.1,"value":6870.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 31, 2026."}],"balance_after":98206,"source":{"system":"sec-edgar","filing":"0001193125-26-139783","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526139783/ownership.xml","form_type":"4"}},{"id":950731,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-05T23:43:41.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":502,"price":13.68,"value":6867.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at December 31, 2025."}],"balance_after":97451,"source":{"system":"sec-edgar","filing":"0001193125-26-002929","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526002929/ownership.xml","form_type":"4"}},{"id":1026744,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T23:06:53.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":315,"price":21.79,"value":6863.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2025."}],"balance_after":96949,"source":{"system":"sec-edgar","filing":"0001193125-25-228831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312525228831/ownership.xml","form_type":"4"}},{"id":1094677,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T20:53:26.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":523,"price":11.94,"value":6244.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at June 30, 2025."}],"balance_after":96634,"source":{"system":"sec-edgar","filing":"0000950170-25-093132","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025093132/ownership.xml","form_type":"4"}},{"id":1135060,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-23T22:12:55.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":12417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders."}],"balance_after":12417,"derivative":{"underlying":"Common Stock","underlying_shares":12417},"source":{"system":"sec-edgar","filing":"0000950170-25-077190","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025077190/ownership.xml","form_type":"4"}},{"id":1142380,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-19T21:07:03.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":false,"shares":21093,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21093},"source":{"system":"sec-edgar","filing":"0000950170-25-074543","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025074543/ownership.xml","form_type":"4"}},{"id":1142379,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T21:07:03.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":true,"shares":21093,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":96111,"source":{"system":"sec-edgar","filing":"0000950170-25-074543","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025074543/ownership.xml","form_type":"4"}},{"id":1182973,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T00:21:29.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":525,"price":11.89,"value":6242.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 31, 2025."}],"balance_after":75018,"source":{"system":"sec-edgar","filing":"0000950170-25-049818","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025049818/ownership.xml","form_type":"4"}},{"id":1314126,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T21:45:38.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":406,"price":15.38,"value":6244.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at December 31, 2024."}],"balance_after":74493,"source":{"system":"sec-edgar","filing":"0000950170-25-001287","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025001287/ownership.xml","form_type":"4"}},{"id":1393999,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T20:22:22.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":557,"price":11.21,"value":6243.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2024."}],"balance_after":74087,"source":{"system":"sec-edgar","filing":"0001285550-24-000113","document":"wk-form4_1727900535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000113/wk-form4_1727900535.xml","form_type":"4"}},{"id":1462498,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T21:21:53.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":1333,"price":5.39,"value":7184.87,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at June 28, 2024."}],"balance_after":73530,"source":{"system":"sec-edgar","filing":"0001285550-24-000086","document":"wk-form4_1719955307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000086/wk-form4_1719955307.xml","form_type":"4"}},{"id":1510996,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-17T20:25:41.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":21093,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders."}],"balance_after":21093,"derivative":{"underlying":"Common Stock","underlying_shares":21093},"source":{"system":"sec-edgar","filing":"0001285550-24-000069","document":"wk-form4_1715977516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000069/wk-form4_1715977516.xml","form_type":"4"}},{"id":1515799,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-15T13:19:53.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":false,"shares":17153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17153},"source":{"system":"sec-edgar","filing":"0001285550-24-000057","document":"wk-form4_1715779184.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000057/wk-form4_1715779184.xml","form_type":"4"}},{"id":1515798,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T13:19:53.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":true,"shares":17153,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":72197,"source":{"system":"sec-edgar","filing":"0001285550-24-000057","document":"wk-form4_1715779184.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000057/wk-form4_1715779184.xml","form_type":"4"}},{"id":1553073,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T20:43:25.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":1056,"price":6.8,"value":7180.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 28, 2024."}],"balance_after":55044,"source":{"system":"sec-edgar","filing":"0001285550-24-000042","document":"wk-form4_1712090587.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000042/wk-form4_1712090587.xml","form_type":"4"}},{"id":1691612,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-03T16:56:56.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":1058,"price":6.79,"value":7183.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at December 29, 2023."}],"balance_after":53988,"source":{"system":"sec-edgar","filing":"0001285550-24-000005","document":"wk-form4_1704301006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000005/wk-form4_1704301006.xml","form_type":"4"}},{"id":1766986,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-03T16:41:14.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":1434,"price":5.01,"value":7184.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2023."}],"balance_after":52930,"source":{"system":"sec-edgar","filing":"0001285550-23-000104","document":"wf-form4_169635125838802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000104/wf-form4_169635125838802.xml","form_type":"4"}},{"id":1835647,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-05T21:46:03.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":992,"price":7.24,"value":7182.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at June 30, 2023."}],"balance_after":51496,"source":{"system":"sec-edgar","filing":"0001285550-23-000078","document":"wf-form4_168859355434556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000078/wf-form4_168859355434556.xml","form_type":"4"}},{"id":1876235,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-26T18:11:56.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":17153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders."}],"balance_after":17153,"derivative":{"underlying":"Common Stock","underlying_shares":17153},"source":{"system":"sec-edgar","filing":"0001285550-23-000064","document":"wf-form4_168512470141759.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000064/wf-form4_168512470141759.xml","form_type":"4"}},{"id":1927494,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T20:56:59.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":851,"price":8.44,"value":7182.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 31, 2023."}],"balance_after":50504,"source":{"system":"sec-edgar","filing":"0001285550-23-000037","document":"wf-form4_168064180220234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000037/wf-form4_168064180220234.xml","form_type":"4"}},{"id":2066578,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T22:58:59.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":901,"price":7.97,"value":7180.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $7.97 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending December 30, 2022."}],"balance_after":49653,"source":{"system":"sec-edgar","filing":"0001285550-23-000007","document":"wf-form4_167287312360999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000007/wf-form4_167287312360999.xml","form_type":"4"}},{"id":2144113,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T22:17:24.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":705,"price":10.19,"value":7183.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $10.19 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending September 30, 2022."}],"balance_after":48752,"source":{"system":"sec-edgar","filing":"0001285550-22-000062","document":"wf-form4_166492182952022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555022000062/wf-form4_166492182952022.xml","form_type":"4"}},{"id":2211652,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-06T18:37:37.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":668,"price":12.63,"value":8436.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $12.63 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending June 30, 2022."}],"balance_after":48047,"source":{"system":"sec-edgar","filing":"0001285550-22-000029","document":"wf-form4_165713264416431.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555022000029/wf-form4_165713264416431.xml","form_type":"4"}},{"id":2253079,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-05-27T20:30:39.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":6179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders."}],"balance_after":6179,"derivative":{"exercise_price":9.71,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":6179},"source":{"system":"sec-edgar","filing":"0001420506-22-001139","document":"doc4_1009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050622001139/doc4_1009.xml","form_type":"4"}},{"id":2253078,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T20:30:39.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":9269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders."}],"balance_after":47379,"source":{"system":"sec-edgar","filing":"0001420506-22-001139","document":"doc4_1009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050622001139/doc4_1009.xml","form_type":"4"}},{"id":2303975,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T21:08:33.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":847,"price":9.96,"value":8436.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $9.96 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2022."}],"balance_after":38110,"source":{"system":"sec-edgar","filing":"0001171520-22-000237","document":"eps10157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000117152022000237/eps10157.xml","form_type":"4"}},{"id":2448303,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T12:18:04.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":730,"price":11.54,"value":8424.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $11.54 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2021."}],"balance_after":37263,"source":{"system":"sec-edgar","filing":"0001171520-22-000015","document":"doc4_990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000117152022000015/doc4_990.xml","form_type":"4"}},{"id":2551665,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T20:14:19.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":470,"price":17.92,"value":8422.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $17.92 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended October 1, 2021."}],"balance_after":36533,"source":{"system":"sec-edgar","filing":"0001420506-21-001360","document":"doc4_970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621001360/doc4_970.xml","form_type":"4"}},{"id":2644129,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T20:17:29.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":296,"price":20.26,"value":5996.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1.These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $20.26 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 30, 2021."}],"balance_after":36063,"source":{"system":"sec-edgar","filing":"0001420506-21-000845","document":"doc4_938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621000845/doc4_938.xml","form_type":"4"}},{"id":2653247,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-06-28T12:38:20.000Z","date":"2021-06-25","kind":"grant","acquired":true,"shares":6006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2022 annual meeting of stockholders."}],"balance_after":6006,"derivative":{"exercise_price":19.98,"expiration_date":"2031-06-25","underlying":"Common Stock","underlying_shares":6006},"source":{"system":"sec-edgar","filing":"0001171520-21-000265","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000117152021000265/ownership.xml","form_type":"4"}},{"id":2653246,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T12:38:20.000Z","date":"2021-06-25","kind":"grant","acquired":true,"shares":3003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2022 annual meeting of stockholders."}],"balance_after":35767,"source":{"system":"sec-edgar","filing":"0001171520-21-000265","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000117152021000265/ownership.xml","form_type":"4"}},{"id":2760819,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T20:05:30.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":322,"price":19.57,"value":6301.54,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $19.57 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2021."}],"balance_after":32764,"source":{"system":"sec-edgar","filing":"0001420506-21-000378","document":"doc4_920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621000378/doc4_920.xml","form_type":"4"}},{"id":2925335,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-04T23:37:46.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":379,"price":15,"value":5685.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $15.00 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2020."}],"balance_after":32422,"source":{"system":"sec-edgar","filing":"0001420506-21-000012","document":"doc4_896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621000012/doc4_896.xml","form_type":"4"}},{"id":3018422,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T22:07:59.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":996,"price":5.71,"value":5687.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $5.71 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2020."}],"balance_after":32063,"source":{"system":"sec-edgar","filing":"0001420506-20-001031","document":"doc4_856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620001031/doc4_856.xml","form_type":"4"}},{"id":3091400,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T17:32:20.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":1570,"price":3.55,"value":5573.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.55 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 30, 2020."}],"balance_after":31067,"source":{"system":"sec-edgar","filing":"0001171520-20-000288","document":"doc4_816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000117152020000288/doc4_816.xml","form_type":"4"}},{"id":3106744,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2020-06-17T20:07:38.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2021 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":4.13,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001420506-20-000689","document":"doc4_810.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000689/doc4_810.xml","form_type":"4"}},{"id":3186157,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-02T20:12:30.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":1505,"price":3.57,"value":5372.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.57 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2020."}],"balance_after":29497,"source":{"system":"sec-edgar","filing":"0001420506-20-000361","document":"doc4_794.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000361/doc4_794.xml","form_type":"4"}},{"id":3326941,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T22:04:06.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":1084,"price":4.96,"value":5376.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $4.96 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2019."}],"balance_after":27992,"source":{"system":"sec-edgar","filing":"0001420506-20-000007","document":"doc4_780.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000007/doc4_780.xml","form_type":"4"}},{"id":3402791,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-01T20:07:18.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":1226,"price":5.15,"value":6313.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $5.15 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2019."}],"balance_after":26908,"source":{"system":"sec-edgar","filing":"0001534424-19-000270","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000270/ownership.xml","form_type":"4"}},{"id":3474554,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-01T20:07:36.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":1993,"price":3.17,"value":6317.81,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.17 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 28, 2019."}],"balance_after":25682,"source":{"system":"sec-edgar","filing":"0001534424-19-000197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000197/ownership.xml","form_type":"4"}},{"id":3495536,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2019-06-10T20:07:40.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2020 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":3.25,"expiration_date":"2029-06-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001534424-19-000174","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000174/ownership.xml","form_type":"4"}},{"id":3568149,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T20:13:58.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":2006,"price":3.15,"value":6318.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.15 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 29, 2019."}],"balance_after":23689,"source":{"system":"sec-edgar","filing":"0001534424-19-000102","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000102/ownership.xml","form_type":"4"}},{"id":3712935,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T22:13:08.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":4294,"price":1.47,"value":6312.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $1.47 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2018."}],"balance_after":21683,"source":{"system":"sec-edgar","filing":"0001534424-19-000012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000012/ownership.xml","form_type":"4"}},{"id":3804206,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-01T20:39:42.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":3592,"price":1.76,"value":6321.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $1.76 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 28, 2018."}],"balance_after":17389,"source":{"system":"sec-edgar","filing":"0001534424-18-000336","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000336/ownership.xml","form_type":"4"}},{"id":3874580,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T20:06:54.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":2668,"price":2.18,"value":5816.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $2.18 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 29, 2018."}],"balance_after":13797,"source":{"system":"sec-edgar","filing":"0001534424-18-000239","document":"girin.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000239/girin.xml","form_type":"4"}},{"id":3898236,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-06-11T12:48:52.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2019 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":2.18,"expiration_date":"2028-06-08","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001534424-18-000207","document":"girin.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000207/girin.xml","form_type":"4"}},{"id":3976193,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-02T20:53:52.000Z","date":"2018-03-30","kind":"grant","acquired":true,"shares":1696,"price":3.13,"value":5308.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.13 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 29, 2018."}],"balance_after":11129,"source":{"system":"sec-edgar","filing":"0001534424-18-000111","document":"girin.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000111/girin.xml","form_type":"4"}},{"id":4088020,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-26T21:05:20.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":2273,"price":2.75,"value":6250.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $2.75 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 29, 2017."}],"balance_after":9433,"source":{"system":"sec-edgar","filing":"0001534424-18-000028","document":"girin.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000028/girin.xml","form_type":"4"}},{"id":4131528,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-12-14T21:19:18.000Z","date":"2017-12-12","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2018 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":2.75,"expiration_date":"2027-12-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001534424-17-000499","document":"girin.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442417000499/girin.xml","form_type":"4"}},{"id":4190912,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-05T20:14:02.000Z","date":"2017-10-04","kind":"grant","acquired":true,"shares":2325,"price":2.47,"value":5742.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $2.47 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 29, 2017."}],"balance_after":7160,"source":{"system":"sec-edgar","filing":"0001534424-17-000416","document":"girin.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442417000416/girin.xml","form_type":"4"}},{"id":4507437,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-03T21:53:59.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":1991,"price":2.64,"value":5256.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under such plan. The shares were issued at a price of $2.64 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 30, 2016."}],"balance_after":4835,"source":{"system":"sec-edgar","filing":"0001534424-17-000013","document":"girin.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442417000013/girin.xml","form_type":"4"}},{"id":4586476,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":45183,"kind":"person","name":"Girin Pascal E R","position":1,"cik":"0001329811","reported_name":"Girin Pascal E R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-04T20:32:14.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":789,"price":6.65,"value":5246.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under such plan. The shares were issued at a price of $6.65 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2016."}],"balance_after":2844,"source":{"system":"sec-edgar","filing":"0001534424-16-001070","document":"girin.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442416001070/girin.xml","form_type":"4"}}]}